Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2654${count})

  • ASAP CRN Discovery Fellowship 2025, 2026
    Network Control of Neuronal Resilience in Parkinson’s Disease
    ASAP logo

    Study Rationale:                         

    In Parkinson’s disease, damage caused by disease processes leads to the death of certain brain cells, but not all cells are equally affected. Some are more...

  • ASAP CRN Discovery Fellowship 2025, 2026
    The Pathogenic Role of Neuronal DNA-Sensing cGAS–STING Pathway in Alpha-Synucleinopathy
    ASAP logo

    Study Rationale:                         

    Parkinson’s Disease (PD) is characterized by neuronal aggregation of toxic alpha-synuclein (aS) protein and subsequent loss of neurons. My research found that...

  • ASAP CRN Discovery Fellowship 2025, 2026
    Unravelling the Impact of the Microbiome on Motor Dysfunction in Parkinson’s Disease Using Phenotypic Heterogeneity in the Pink1-/- Infection-Induced Disease Model
    ASAP logo

    Study Rationale:                         

    Development of Parkinson’s Disease (PD) involves genetic and environmental factors. Not all people with genetic risk factors for PD develop the disease...

  • Research Grant, 2026
    Automated Platform for Standardizing and Validating GBA1 Human iPSC Models To Accelerate Mechanistic and Therapeutic Discovery in Parkinson’s Disease

    Study Rationale: Mutations in the GBA1 gene are the most common known genetic risk factors for Parkinson’s disease (PD). Individuals who carry these mutations not only have an increased risk of...

  • Parkinson’s Disease Therapeutics Pipeline Program - Pre-Clinical, 2026
    LARKIN

    Study Rationale:                   

    Parkinson’s disease is a progressive brain disorder in which dopamine-producing nerve cells gradually die, leading to worsening movement and other symptoms. Research...

  • Summer 2025 RFA: Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research Program, 2026
    PWR-PD (“Power-PD”): Personalized Wearable-based Rehabilitation for Parkinson’s Disease

    Study Rationale:                   

    Gait impairments are common among people with Parkinson’s disease (PD), leading to an increased fall risk and a reduced quality of life. More and more people are...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.